Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-10
2007-04-10
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S224000, C544S336000, C544S358000
Reexamination Certificate
active
10446627
ABSTRACT:
Disclosed are novel inhibitors of Chk-1 and methods of using the same for therapy.
REFERENCES:
patent: 1 153 920 (2001-11-01), None
patent: 1 199 306 (2002-04-01), None
patent: WO 02/070494 (2002-09-01), None
patent: WO 02/070494 (2002-09-01), None
Jackson, J. R., et al., “An Indolocarbazole Inhibitor of Human Checkpoint Kinase (Chk1) Abrogates Cell Cycle Arrest Caused by DNA Damage”,Cancer Research,60: 566-572 (2000).
Boyle Robert George
Cherry Michael
Imogai Hassan Julien
Hamilton Brook Smith & Reynolds PC
Millennium Pharmaceuticals Inc.
Ward Paul V.
Wilson James O.
LandOfFree
Chk-1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chk-1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chk-1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3795030